Security key
H82027105
SOPHiA GENETICS SA - Ordinary Shares, CHF 0.05 per share (SOPH)
CUSIP: H82027105
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Ordinary Shares, CHF 0.05 per share
- Total 13F shares
- 21,657,498
- Total 13F value
- $167,456,888
- Share change
- +3,042,405
- SEC-reported price per share
- $7.73
- Number of holders
- 27
- Value change
- +$22,365,366
- Number of buys
- 13
- Number of sells
- 19
- Shares outstanding
- 67,372,245
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
27
Top holders
10
SOPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
SOPHiA GENETICS SA SEC filings
SOPHiA GENETICS SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP H82027105
Recent filing periods:
Ownership snapshot
Top reported holders of SOPH - SOPHiA GENETICS SA - Ordinary Shares, CHF 0.05 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GENERATION INVESTMENT MAN...
Disclosed value leader
GENERATION INVESTMENT MAN...
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
GENERATION INVESTMENT MANAGEMENT LLP leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GENERATION INVESTMENT MANAGEMENT LLP's linked filing trail.
Comparable ownership
Top 5
GENERATION INVESTMENT MANAGEMENT LLP
10%
PRICE T ROWE ASSOCIATES INC /MD/
3.5%
PFM Health Sciences, LP
2.9%
CREDIT SUISSE AG/
2.7%
JENNISON ASSOCIATES LLC
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP |
13F
Company
|
10%
|
$95,733,000
6,789,560 shares
|
— | 31 Dec 2021 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
3.5%
|
$33,590,000
2,382,304 shares
|
— | 31 Dec 2021 |
| PFM Health Sciences, LP |
13F
Company
|
2.9%
|
$27,525,000
1,952,152 shares
|
— | 31 Dec 2021 |
| CREDIT SUISSE AG/ |
13F
Company
|
2.7%
|
$26,030,000
1,846,104 shares
|
— | 31 Dec 2021 |
| JENNISON ASSOCIATES LLC |
13F
Company
|
2.1%
|
$20,326,000
1,441,590 shares
|
— | 31 Dec 2021 |
| GENERAL ELECTRIC CO |
13F
Company
|
1.6%
|
$15,666,665
1,111,111 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
27
Shares
21,657,498
Rows available
27
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q4 2025 Across Filers
Q4 2025 holders
42
Q1 2022 holders
27
Holder diff
-15
| Investor | Q4 2025 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend